SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
35
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Desarrolladora Homex, S.A.B. de C.V. (HXM, DHOXQ, DHOXY, DHHXF) & Lead Plaintiff Deadline: May 15, 2017

NEW YORK, March 23, 2017 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Desarrolladora Homex, S.A.B. de C.V.   (“Homex” or the “Company”) (OTCMKTS:DHHXF) (formerly (NYSE: HXM ); formerly (OTCMKTS:DHOXQ); formerly (OTCMKTS:DHOXY)) and certain of its officers, on behalf of shareholders who purchased Homex American Depositary Shares between April 30, 2012 and May 5, 2016, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/hxm .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. 

The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and failed to disclose that: (1) between 2010 and 2013, Homex overstated its revenue by 355% or roughly $3.3 billion by reporting fictitious sales of more than 100,000 homes; (2) between 2010 and 2013, Homex overstated the number of units it sold by over 100,000 units or 317% of actual units sold; (3) Homex and certain of its Headquarters Financial Reporting Personnel knowingly and intentionally engaged in a scheme to materially overstate Homex’s revenues, homes sold, and other related financial items; and (4) consequently, defendants’ statements about Homex’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On March 3, 2017, Homex decided to resolve its charges with the U.S. Securities and Exchange Commission (“SEC”) for allegedly reporting $3.3 billion in deceitful sales revenue to boost its revenues in financial statements between 2010 and 2013. The SEC’s complaint alleges that during a three-year period, Homex exaggerated its revenue by 355%, or about $3.3 billion by reporting fabricated sales of more than 100,000 homes, thereby four times inflating the numbers of homes actually sold. The SEC’s complaint also alleges that “Homex’s Headquarters Financial Reporting Personnel intentionally and knowingly uploaded false information into the Company’s internal reporting and accounting systems in order to perpetrate the fictitious revenue scheme.”

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/hxm  or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Homex you have until May 15, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 0

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
U.S. Gold Corp. Gears Up for Key October Event

Updated Category News Views 37

Marking Calendars for the Emerging Growth Showdown There's nothing quite like the buzz leading up to an event where you know someone’s either gonna make a splash or barely leave a ripple. U.S. Gold Corp. is drawing some attention ahead of the Emerging Growth Conference on October 29, 2026. This ain't just any corporate dog-and-pony show—it's a chance for the Gold...

Continue Reading
Ellucian's Cloud Hat-Trick: Leading AI in Education

Updated Category News Views 66

Turning the Dial on Cloud Innovation What’s gripping the talk of the town? It's the powerhouse, Ellucian, clinching the 2026 Stratus Award for Cloud Computing in the Education category, marking a third straight victory. It’s a trifecta that signals something big in the world of higher ed tech. But what does it mean for investors and the sector at large? Unpacking the...

Continue Reading
Medefy's New Award Honors Cost-Savvy Consultants

Updated Category News Views 59

Awarding Ingenuity in Healthcare Cost Containment Ditch the chatter, folks. Let’s talk about a little piece of news that just might be the ripple effect the healthcare sector needs right now. Medefy, that cost-containment whiz, has unleashed 'The Curve Bender Award.' Frankly, it's about time someone spotlighted the gritty work of benefits consultants grinding in the...

Continue Reading
Nektar Therapeutics Gears Up for Q3 Financial Reveal

Updated Category News Views 34

Anticipation Builds as Nektar Preps Financial Report Ah, the life of a biotech investor, riding high or gripping the rail as tides turn with every quarterly report. This time, we're turning our gaze to Nektar Therapeutics and their Q3 financial results slated for release on November 12th, just as the market dust starts settling for the day. Now, if you’re wired to...

Continue Reading
Innodata Faces Investigation After Major Stock Drop

Updated Category News Views 26

Rough Waters for Innodata, Stock Takes a Hit The market can be a brutal place when news hits hard, and that's precisely the situation Innodata Inc. (NASDAQ: INOD) found itself in on October 27, 2026. After a promising rally, the company's shares plummeted by over 20% when news broke of a significant workforce reduction overseas. Unpacking the Numbers Behind the Dive The...

Continue Reading
Fashion Sees Quality Trumping Price in Consumer Preferences

Updated Category News Views 22

Consumers Are Shifting Away from Price-First Mindset You could always count on shoppers looking for a bargain, right? Well, hold your horses, 'cause that train's rolling off the tracks. In today's fashion shuffle, good ol' quality and craftsmanship are giving low prices a run for their money. A study spearheaded by Boston Consulting Group (BCG) and Women's Wear Daily...

Continue Reading
Ferrovial's EUR 600M Scrip Dividend: What's Brewing?

Updated Category News Views 68

Understanding Ferrovial's Latest Financial Maneuver Alright, investors, listen up—Ferrovial's just tossed a hefty EUR 600 million scrip dividend onto the table, giving shareholders the choice between cash or shares. Now, if you've been around the block, this sort of move can mean a few things, and it's best not to treat it like coins rattling in a collection plate. This...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 51

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Covalent's Bet on AML Analytics: A Defense Revolution

Updated Category News Views 11

The Big Play: AI Meets Financial Defense You know when a private equity firm swoops in, it's like the cavalry arriving. Covalent Equity Partners just did that for AML Analytics, or AMLA for short. A payday for them, sure, but it's more about amplifying AMLA's already hefty punch against financial crime, using AI to boot. Now, if AI's mentioned, you know someone's getting...

Continue Reading

Top 5 Most Recently Viewed Articles

Defense Metals Welcomes Ali Mahdavi as New SVP for Growth

Updated Category News Views 262

Defense Metals Welcomes Ali Mahdavi as New SVP for Growth Defense Metals Corp. (TSXV: DEFN) is thrilled to announce that Ali Mahdavi has joined as Senior Vice President of Corporate Development. This strategic appointment aims to bolster the Company's leadership team as they work diligently on their Wicheeda Project. Strengthening Leadership for Strategic Growth Mark...

Continue Reading
Insightful Economic Trends Expected by Chapman University 2026

Updated Category News Views 150

Understanding the Chapman University Economic Forecast for 2026 Chapman University has disclosed key insights from its much-anticipated economic forecast for 2026, a resource utilized for nearly five decades by business leaders and policymakers. The report highlights expectations for real GDP growth of approximately 2.0% in 2026, a noticeable increase from the predicted...

Continue Reading
Pyxis Oncology Welcomes New Vice President for Investor Relations

Updated Category News Views 192

Introduction to Alex Kane's Appointment Pyxis Oncology, Inc. (NASDAQ: PYXS), a pioneering clinical-stage firm dedicated to developing antibody-drug conjugates for challenging cancers, has taken a significant step by appointing Alex Kane as their Senior Vice President of Investor Relations and Capital Markets, effective immediately. Alex Kane's Impressive Background...

Continue Reading
CEO Terry Mendez's Vision for Safe Harbor Financial Success

Updated Category News Views 508

Terry Mendez’s Vision for Safe Harbor Financial's Future GOLDEN, Colo. — SHF Holdings, Inc., operating as Safe Harbor Financial (Nasdaq: SHFS), is reaching a pivotal moment in its journey. In a recent announcement, the newly appointed CEO, Terry Mendez, addressed shareholders, sharing his aspirations and strategic focus for the company. As a key player in providing...

Continue Reading
Gentuity's HF-OCT Imaging System Gains FDA Clearance

Updated Category News Views 75

Gentuity's HF-OCT Imaging System Gains FDA Clearance Gentuity, LLC, a leader in innovative intravascular imaging technologies, has recently celebrated a significant triumph with the FDA's approval of its HF-OCT Imaging System. This cutting-edge device is designed for both pre- and post-percutaneous coronary intervention (PCI) imaging, marking it as a groundbreaking tool...

Continue Reading